Global Medical REIT (NYSE:GMRE) Issues FY 2025 Earnings Guidance

Global Medical REIT (NYSE:GMRE) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 4.500-4.600 for the period, compared to the consensus EPS estimate of 4.130. The company issued revenue guidance of -.

Analyst Ratings Changes

A number of brokerages recently issued reports on GMRE. Weiss Ratings reiterated a “hold (c-)” rating on shares of Global Medical REIT in a report on Wednesday, October 8th. Citigroup upgraded Global Medical REIT to an “outperform” rating in a report on Monday, October 13th. JMP Securities set a $40.00 price target on Global Medical REIT and gave the company a “market outperform” rating in a report on Monday, October 13th. Zacks Research upgraded Global Medical REIT from a “hold” rating to a “strong-buy” rating in a report on Wednesday, September 24th. Finally, Citizens Jmp upgraded Global Medical REIT from a “market perform” rating to an “outperform” rating and set a $40.00 price target for the company in a report on Monday, October 13th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Global Medical REIT has an average rating of “Moderate Buy” and a consensus price target of $42.50.

Global Medical REIT Stock Down 0.4%

Shares of NYSE:GMRE traded down $0.12 during trading hours on Tuesday, hitting $30.34. The company’s stock had a trading volume of 203,357 shares, compared to its average volume of 144,426. Global Medical REIT has a 52 week low of $30.03 and a 52 week high of $47.00. The company has a debt-to-equity ratio of 1.56, a current ratio of 0.28 and a quick ratio of 0.28. The company has a market capitalization of $405.98 million, a price-to-earnings ratio of 86.69 and a beta of 1.17. The firm’s fifty day moving average price is $34.37 and its 200 day moving average price is $34.35.

Global Medical REIT (NYSE:GMRE) last posted its quarterly earnings results on Tuesday, November 4th. The company reported $1.12 EPS for the quarter, beating the consensus estimate of $1.05 by $0.07. Global Medical REIT had a net margin of 7.32% and a return on equity of 2.21%. Global Medical REIT has set its FY 2025 guidance at 4.500-4.600 EPS. As a group, research analysts expect that Global Medical REIT will post 0.81 EPS for the current year.

Global Medical REIT Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Monday, September 29th were given a dividend of $0.75 per share. The ex-dividend date of this dividend was Monday, September 29th. This is a boost from Global Medical REIT’s previous quarterly dividend of $0.15. This represents a $3.00 dividend on an annualized basis and a dividend yield of 9.9%. Global Medical REIT’s payout ratio is currently 857.14%.

Global Medical REIT declared that its Board of Directors has initiated a share repurchase program on Wednesday, August 13th that allows the company to buyback $50.00 million in outstanding shares. This buyback authorization allows the company to repurchase up to 11.1% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s management believes its stock is undervalued.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of GMRE. Invesco Ltd. boosted its stake in shares of Global Medical REIT by 30.5% during the 2nd quarter. Invesco Ltd. now owns 1,518,668 shares of the company’s stock worth $10,524,000 after acquiring an additional 355,355 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Global Medical REIT by 8.6% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 1,514,954 shares of the company’s stock worth $10,499,000 after acquiring an additional 119,538 shares in the last quarter. Man Group plc boosted its stake in shares of Global Medical REIT by 1.7% during the 2nd quarter. Man Group plc now owns 600,943 shares of the company’s stock worth $4,165,000 after acquiring an additional 10,192 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Global Medical REIT by 13.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 388,605 shares of the company’s stock worth $3,400,000 after acquiring an additional 45,243 shares in the last quarter. Finally, Marshall Wace LLP boosted its stake in shares of Global Medical REIT by 2,208.2% during the 2nd quarter. Marshall Wace LLP now owns 291,708 shares of the company’s stock worth $2,022,000 after acquiring an additional 279,070 shares in the last quarter. Institutional investors and hedge funds own 57.52% of the company’s stock.

About Global Medical REIT

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.